Xconomy: Boston News, Articles and Opinions

Results for “”

Entry	Author	Date	Location
Why My Company Chose Boston, Not Silicon Valley, for Its US HQ	Fred de Gombert	06/17/19	Boston
Unum Therapeutics Appoints Jessica Sachs Chief Medical Officer	Frank Vinluan	06/14/19	Boston
Bluebird Bio Sets $1.8M Price on Gene Therapy for Rare Blood Disease	Frank Vinluan	06/14/19	Boston
Bio Roundup: Roche-Spark Drags On, GSK Taps CRISPR, Diabetes News & More	Ben Fidler	06/14/19	National
Your Tech Startup Is Probably Not Ready to Raise Money	Al Bsharah	06/13/19	San Diego
IPO Scorecard: CrowdStrike Gains 70 Percent on First Trading Day	Bernadette Tansey	06/12/19	San Francisco
Akrevia Taps Joseph Farmer for Chief Operating Officer Post	Frank Vinluan	06/12/19	Boston
Ex-Dermavant Exec Jassie Joins eGenesis as Chief Business Officer	Frank Vinluan	06/12/19	Boston
Synlogic Lands $80M from Ginkgo to Ramp Up “Living Medicines” R&D	Frank Vinluan	06/12/19	Boston
Hi Marley Raises $8M From Investors to Streamline Insurance With AI	Brian Dowling	06/12/19	Boston
Celsius Therapeutics Appoints Tariq Kassum President & CEO	Frank Vinluan	06/11/19	Boston
Trust No One: Edgewise Raises $11M to Segment and Secure Networks	Brian Dowling	06/11/19	Boston
Artizan Bio Taps Synlogic’s Paul Miller for Chief Scientific Officer	Frank Vinluan	06/10/19	Boston
With Yale Tech and $12M, Artizan Aims for Root Cause of Gut Disease	Frank Vinluan	06/10/19	Boston
Merck Bags Tilos, Adding an Immunotherapy Booster to Its Arsenal	Ben Fidler	06/10/19	Boston
3 Tips to Boost Security, Trust With Increasingly Remote Workforce	Mike McKee	06/10/19	Boston
Tealium CEO, Founder Among San Diego’s Entrepreneurs of the Year	Sarah de Crescenzo	06/07/19	Boston
Vertex Pharma Shells Out $420M to Move Into Muscular Dystrophy	Frank Vinluan	06/07/19	Boston
Boston Tech Watch: IKEA and Ori, Skyworks and Huawei & Massport and Turo	Brian Dowling	06/07/19	Boston
Bio Roundup: ASCO Wrap, Bluebird’s EU Tap, CRISPR Baby Risk & More	Alex Lash	06/07/19	National
Agios Chief Scientific Officer Scott Biller to Retire at End of Year	Frank Vinluan	06/06/19	Boston
BlueRock’s Lodie Joins Gamida Cell as Chief Scientific Officer	Frank Vinluan	06/06/19	Boston
Cerf, Kahn, Perlman, Hillis & More at Net@50: Get Tix to Historic Event	Robert Buderi	06/05/19	Boston
Ex-Vertex Pharma Exec Patricia Hurter to Join Lyndra as CEO	Frank Vinluan	06/05/19	Boston
ASCO 2019: The Long Game, Targeted Pills, First-Ever Buzz & More	Alex Lash	06/05/19	National
Apple Touts New Privacy Moves as Antitrust Probes Loom for Big Tech	Bernadette Tansey	06/04/19	San Francisco
What’s Hot in Boston Biotech 2019: The Photos	Jeff Engel	06/04/19	Boston
Bayer and Arvinas Join Forces in $115M Pharma & Ag Research Alliance	Frank Vinluan	06/04/19	Boston
Study: Gene Edits in CRISPR Babies Could Boost Risk of Earlier Death	Alex Lash	06/03/19	National
Bluebird Bio’s Gene Therapy for Blood Disease Wins European Approval	Frank Vinluan	06/03/19	Boston
Page 1 of 650	next page »